NIPPOBATRYBSEIndo National LtdHighNeutral
Announced Fri, 15 May · 17:30 IST

results for the quarter and year ended 31st march 2026

Pat NegativeRevenue DeclineRelated Party TransactionsResults View source PDF

NIPPOBATRY · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-11.8%1-day move
₹383.05
prior close
₹367.55
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.1-1.7-3.2-3.2-11.8-12.6-6.5-8.1-3.8-3.3-7.9-5.4-14.0
Up moveDown movePending
AI summary

Indo National Ltd (Nippo) reported a significant turnaround from profit to loss for FY26. Standalone revenue declined slightly to Rs. 45,101 Lakhs from Rs. 45,797 Lakhs, while the company swung to a standalone loss of Rs. 1,040 Lakhs versus profit of Rs. 101 Lakhs in FY25. Consolidated results show an even larger loss of Rs. 2,669 Lakhs versus profit of Rs. 12,195 Lakhs previously, with consolidated revenue at Rs. 45,249 Lakhs. The company acquired Medcuore Medical Solutions (54.79% stake for Rs. 694 Lakhs) and invested Rs. 850 Lakhs in Axial Aero CCPS. A Rs. 4,226 Lakh CCI penalty remains stayed pending appeal. The board recommended dividend of Rs. 3.75 per share despite the loss. New labour codes resulted in Rs. 86-87 Lakhs past period liability. The auditors issued an unmodified opinion.

Likely market impact

The company has swung from profit to substantial loss, indicating significant operational stress. Revenue declined marginally. Despite the loss, the board maintained dividend recommendation, which may signal management confidence or shareholder pressure. The large consolidated loss is partly driven by the investment segment performing poorly.